MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing

Gene

Volumn 572, Issue 2, 2015, Pages 191-197

  Rounds, William H ^a   Salinas, Edward A ^b   Wilks, Tom B ^e   Levin, Mikhail K ^b   Ligocki, Ann J ^a   Ionete, Carolina ^c   Pardo, Carlos A ^d   Vernino, Steven ^a   Greenberg, Benjamin M ^a   Bigwood, Douglas W ^e   Eastman, Eric M ^e   Cowell, Lindsay G ^b   Monson, Nancy L ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UMASS MEMORIAL MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e DioGenix Inc   (United States)

Author keywords

B cell; Biomarker; Genetics; High throughput nucleotide sequencing; Multiple sclerosis; Neurological disease

Indexed keywords

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE MUTATION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; MALE; MOLECULAR DIAGNOSTICS; MULTIPLE SCLEROSIS; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; CEREBROSPINAL FLUID; DNA MUTATIONAL ANALYSIS; GENETICS; MIDDLE AGED; MOLECULAR DIAGNOSIS; MULTIGENE FAMILY; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROCEDURES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; DNA MUTATIONAL ANALYSIS; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIGENE FAMILY; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84941599121     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.07.011     Document Type: Article

References (26)

1. Andersson M., Alvarez-Cermeno J., Bernardi G., et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J. Neurol. Neurosurg. Psychiatry 1994, 57:897-902.
2. Antel J., Bar-Or A. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment. J. Neuroimmunol. 2006, 180:3-8.
3. Baranzini S.E., Jeong M.C., Butunoi C., Murray R.S., Bernard C.C., Oksenberg J.R. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J. Immunol. 1999, 163:5133-5144.
4. Bennett J.L., Haubold K., Ritchie A.M., et al. CSF IgG heavy-chain bias in patients at the time of a clinically isolated syndrome. J. Neuroimmunol. 2008, 199:126-132.
5. Boyd S.D., Marshall E.L., Merker J.D., et al. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci. Transl. Med. 2009, 1:12ra23.
6. Brezinschek H.P., Brezinschek R.I., Lipsky P.E. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J. Immunol. 1995, 155:190-202.
7. Cameron E.M., Spencer S., Lazarini J., et al. Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. J. Neuroimmunol. 2009, 213:123-130.
8. Colombo M., Dono M., Gazzola P., et al. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J. Immunol. 2000, 164:2782-2789.
9. Evdoshenko E., Maslyanskiy A., Lapin S., et al. Dynamics of B-cell populations in CSF and blood in patients treated with a combination of rituximab and mitoxantrone. ISRN Neurol. 2013, 2013:748127.
10. Harp C., Lee J., Lambracht-Washington D., et al. Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection. J. Neuroimmunol. 2007, 183:189-199.
11. Hauser S.L., Waubant E., Arnold D.L., et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 2008, 358:676-688.
12. Kappos L., Li D., Calabresi P.A., et al. Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet 2011, 378:1779-1787.
13. Kroksveen A.C., Opsahl J.A., Guldbrandsen A., et al. Cerebrospinal fluid proteomics in multiple sclerosis. Biochim. Biophys. Acta 2014, 1854:746-756.
14. Krumbholz M., Derfuss T., Hohlfeld R., Meinl E. B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat. Rev. Neurol. 2012, 8:613-623.
15. Lambracht-Washington D., O'Connor K.C., Cameron E.M., et al. Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS. J. Neuroimmunol. 2007, 186:164-176.
16. Monson N.L., Brezinschek Hans-Peter, Brezinschek Ruth I., et al. Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients. J. Neuroimmunol. 2005, 158:170-181.
17. Monson N.L., Cravens P.D., Frohman E.M., Hawker K., Racke M.K. Effect of Rituximab on the peripheral blood and cerebrospinal fluid b cells in patients with primary progressive multiple sclerosis. Arch. Neurol. 2005, 62:258-264.
18. Owens G.P., Kraus H., Burgoon M.P., Smith-Jensen T., Devlin M.E., Gilden D.H. Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann. Neurol. 1998, 43:236-243.
19. Owens G.P., Ritchie A.M., Burgoon M.P., Williamson R.A., Corboy J.R., Gilden D.H. Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J. Immunol. 2003, 171:2725-2733.
20. Owens G.P., Winges K.M., Ritchie A.M., et al. VH4 gene segments dominate the intrathecal humoral immune response in multiple sclerosis. J. Immunol. 2007, 179:6343-6351.
21. Polman C.H., Reingold S.C., Banwell B., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011, 69:292-302.
22. Qin Y., Duquette P., Zhang Y., Talbot P., Poole R., Antel J. Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. J. Clin. Invest. 1998, 102:1045-1050.
23. Rounds W.H., Ligocki A.J., Levin M.K., et al. The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencing. Front. Neurol. 2014, 5:166.
24. Stuve O., Bennett J.L. Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri) in inflammatory diseases. CNS Drug Rev. 2007, 13:79-95.
25. von Budingen H.C., Harrer M.D., Kuenzle S., Meier M., Goebels N. Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies. Eur. J. Immunol. 2008, 38:2014-2023.
26. von Budingen H.C., Kuo T.C., Sirota M., et al. B cell exchange across the blood-brain barrier in multiple sclerosis. J. Clin. Invest. 2012, 122:4533-4543.